BANGKOK PEPTIDES · THAILAND
Retatrutide
Retatrutide supplied by Bangkok Peptides as a lyophilised research vial.
- Compound
- Retatrutide
- Supplier format
- Vial
- Listed strength
- 10mg / 20mg / 30mg / 40mg
- Snapshot
- 2026-11-08
Recorded product options
Prices are supplier snapshot values, not a live quote.
Visit Bangkok Peptides (opens in a new tab)Referral link; we may earn a commission.
SAMPLE DOCUMENTS
Reports linked to this listing
Supplier section labels do not establish independent authenticity or apply a named sample result to every unit.
| Sample / batch | Recorded date | Purity | Amount | Source placement |
|---|---|---|---|---|
| Retatrutide 10mgBP-RT10-1026 | 2026-09-24 | 99.674% | 10.7 mg | Supplier latest section |
| Retatrutide 20mgBP-RT20-1026 | Not recorded | 99.761% | Not recorded | Supplier latest section |
| Retatrutide 30mgBP-RT30-1026 | Not recorded | 99.4% | Not recorded | Supplier latest section |
| Retatrutide 40mgBP-RT40-0926 | Not recorded | 99.788% | Not recorded | Supplier latest section |
| Retatrutide 10mgBP-RT10-0926 | Not recorded | 99.914% | Not recorded | Historical report |
| Retatrutide 20mgBP-RT20-0826 | Not recorded | 99.816% | Not recorded | Historical report |
| Retatrutide 30mgBP-RT30-08-26 | Not recorded | 99.786% | Not recorded | Historical report |
| Retatrutide 10mgBP-RT10-0826 | Not recorded | 99.427% | Not recorded | Historical report |
| Retatrutide 10mgBP-RT10-0426 | Not recorded | 99.308% | Not recorded | Historical report |
| Retatrutide 20mgBP-RT20-0426 | Not recorded | 99.694% | Not recorded | Historical report |
| Retatrutide 30mgBP-RT30-0426 | Not recorded | 99.762% | Not recorded | Historical report |
| Retatrutide 10mgBP-RT10-0226 | Not recorded | 99.573% | Not recorded | Historical report |
| Retatrutide 20mgBP-RT20-0226 | Not recorded | 99.619% | Not recorded | Historical report |
| Retatrutide 30mgBP-RT30-0226 | Not recorded | 99.726% | Not recorded | Historical report |
READING IN CONTEXT
Research background / บทความวิจัย
These Markdown guides discuss compounds and evidence. They do not review the clinical performance of this supplier’s product.